FIELD: biotechnology.
SUBSTANCE: invention relates to novel biologically active derivatives of 1-(1-adamantyl)ethylamine (remantadine) representing adamantyl peptides having antiviral action. The invention may find application in medicine, pharmacology and virology as new medicinal products to treat Hepatitis C.
EFFECT: obtained new low-toxic compounds have selective antiviral activity against Hepatitis C virus.
3 cl, 6 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLOHEXANOXYCARBONYL-DIPEPTIDE AND ITS ANTIVIRAL ACTIVITY AGAINST HEPATITIS C VIRUS | 2017 |
|
RU2641297C1 |
DERIVATIVES OF 1-(1-ADAMANTYL)ETHYLAMINE-N-ACYLAMINOACIDES AND THEIR ANTI-INFLUENZA ACTIVITY | 2014 |
|
RU2572102C1 |
ADAMANTYLAMIDES OF SULFUR-CONTAINING ACIDS AND THEIR ANTI-INFLUENZA ACTIVITY | 2015 |
|
RU2617850C1 |
2-QUINALDICARBOXYLIC ACID DERIVATIVES AND THEIR ANTI-INFLUENZA ACTIVITY | 2015 |
|
RU2624906C2 |
STRAIN VIRUS HEPATITIS C, D-1, FOR PREPARING DIAGNOSTIC AND PROPHYLACTIC PREPARATIONS | 1997 |
|
RU2130967C1 |
ANTIVIRAL AGENT | 2014 |
|
RU2564919C1 |
1-(1-ADAMANTYL)ETHYLAMINE DERIVATIVES AND THEIR ANTIVIRAL ACTIVITY | 2011 |
|
RU2461544C1 |
METHOD OF PRODUCTION OF POLYSURMIN ADSORBENT | 2007 |
|
RU2324535C1 |
ANTIVIRAL COMPOUND OF MULTIPLE ACTION, ITS COMPOSITION AND METHOD OF TREATING VIRAL DISEASES | 2012 |
|
RU2597150C2 |
ANTIVIRAL AGENT AGAINST TICK-BORNE ENCEPHALITIS VIRUS | 2022 |
|
RU2812292C1 |
Authors
Dates
2014-07-27—Published
2013-04-09—Filed